Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and TS-1 in Advanced Pancreatic Cancer
NCT00436423Phase 2Completed
- Sponsor
- Korea University Anam Hospital
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tegafur in pancreatic cancer (PC), sponsored by Korea University Anam Hospital. Primary endpoint: Response rate by RECIST criteria. Started Mar 2006; status: completed.
02
Drugs
tegafur
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00436423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00436423.